Loading...
Functional Impairment of Human Resident Cardiac Stem Cells by the Cardiotoxic Antineoplastic Agent Trastuzumab
Trastuzumab (TZM), a monoclonal antibody against the ERBB2 protein, increases survival in ERBB2-positive breast cancer patients. Its clinical use, however, is limited by cardiotoxicity. We sought to evaluate whether TZM cardiotoxicity involves inhibition of human adult cardiac-derived stem cells, in...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AlphaMed Press
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3659699/ https://ncbi.nlm.nih.gov/pubmed/23197808 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5966/sctm.2011-0016 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|